Stanford University
Showing 1-100 of 1,600 Results
-
Ali Abdelhafiz
Fellow in Pediatrics - Cardiology
BioPediatric Cardiac Critical Care Fellow at Lucile Packard Children's Hospital, Stanford University.
-
Marwa Abu El Haija
Clinical Associate Professor, Pediatrics - Gastroenterology
BioI am a pediatric gastroenterologist with clinical and research interest in childhood obesity. I believe that each patient is unique in their disease and background, that is why they deserve to be approached in an individualized way. I aspire to discover what's unknown about the pathophysiologic causes of obesity, and the mechanisms of which treatments work. My clinical and research interests in pediatric obesity found home within Stanford's distinctive position academically, medically and geographically.
-
Janelle Aby
Clinical Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsMy interest is in the care and evaluation of newborns. In particular, I have been focusing on improving the educational experience for our residents and students in the nursery regarding the examination and management of term or near-term infants.
-
Maya Adam
Clinical Associate Professor, Pediatrics - Infectious Diseases
BioDr. Adam is the Director of Health Media Innovation and a Clinical Associate Professor in the Department of Pediatrics at Stanford School of Medicine. Her research focuses on measuring the impact of innovative, video-based entertainment-education approaches to global health communication. She produces short, animated films and online courses on topics related to maternal child health, nutrition, mental health and disease prevention. She has designed and produced online educational content for the Stanford School of Medicine for use in their preclinical programs, continuing medical education programs and global health promotion efforts. She is the Faculty Lead for the Global Child Health Media Initiative and Associate Director of the Center for Digital Health at Stanford. She is also the lead instructor of eight massive open online courses reaching more than a million learners around the world. Adam is principal investigator on two randomized-controlled trials investigating the impact of digital global health education interventions on health-promoting behaviors. Her research is conducted in collaboration with the Heidelberg Institute of Global Health in Heidelberg, Germany. She is a Faculty Fellow at the Center for Innovation in Global Health and the author of Food, Love, Family: A Practical Guide to Child Nutrition.
-
Alyce Sophia Adams
Stanford Medicine Innovation Professor and Professor of Epidemiology and Population Health, of Health Policy and, by courtesy, of Pediatrics (Endocrinology)
BioDr. Adams is the inaugural Stanford Medicine Innovation Professor and Professor of Health Policy, Epidemiology and Population Health and of Pediatrics (by Courtesy). She also serves as Associate Chair for Community Outreach and Engagement for Stanford Health Policy, and as Associate Director for Partnership and Community Engagement in the Stanford Cancer Institute. Focusing on pharmaceutical treatments for cancer and diabetes, Dr. Adams' research evaluates health system and policy level interventions to improve access, balance the benefits and harms of treatment, improve patient-valued outcomes, and reduce disparities. Prior to joining Stanford School of Medicine, Dr. Adams was Associate Director for Health Care Delivery and Policy and a Research Scientist at the Kaiser Permanente Division of Research, as well as a Professor at the Bernard J. Tyson Kaiser Permanente School of Medicine. From 2000 to 2008, she was an Assistant Professor in the Department of Population Medicine (formerly Ambulatory Care and Prevention) at Harvard Medical School and Harvard Pilgrim Health Care. She received her PhD in Health Policy and an MPP in Social Policy from Harvard University. She is a member of the Stanford University Faculty Senate and a former recipient of the John M. Eisenberg Excellence in Mentoring Award from Agency for Healthcare Research and Quality.
-
Leslie Adams
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health) and, by courtesy, of Pediatrics
BioLeslie Adams, PhD, MPH is an Assistant Professor in the Division of Public Mental Health and Population Sciences at Stanford University School of Medicine, where she focuses on addressing mental health disparities among people of African descent and marginalized communities. As a behavioral scientist, her research emphasizes the role of structural racism, gender norms, and psychosocial stressors in influencing mental health outcomes. Dr. Adams employs mixed-methods approaches, including ecological momentary assessment and passive data sensing, to explore real-time stressors like racial discrimination and their link to depressive symptoms and suicidality. Prior to her role at Stanford, she served as an Assistant Professor at Johns Hopkins Bloomberg School of Public Health and was a David E. Bell Postdoctoral Fellow at the Harvard Center for Population and Development Studies.
-
Ananta Addala
Assistant Professor of Pediatrics (Endocrinology)
BioDr. Ananta Addala is a pediatric endocrinologist and physician scientist at Stanford University addressing access in pediatric type 1 diabetes management and outcomes. As a physician with a background in pediatric endocrinology, epidemiology, and behavioral health, she aims to build an evidence-based approach to addressing T1D disparities by systematically evaluating youth-, family-, provider-, and system-level barriers to optimal diabetes care in youth who underutilize diabetes technology.
To date, her publications have demonstrated that the disparities in pediatric T1D by socioeconomic status are worsening in the US, provider bias against public insurance is common, and public insurance mediated interruptions to diabetes technology adversely impact glycemic outcomes. She has been leading efforts to recruit and retain individuals living with or at risk for a condition in clinical trials, through engagement initiatives, her leadership at Stanford Pediatrics, and her role as co-chair of TrialNet's Recruitment Engagement Committee. -
Sophia Adelson
Rsch Data Analyst 2, Pediatrics - Genetics
BioSophia Adelson is a Research Genetic Counselor in the Department of Pediatrics, Division of Genetics at Stanford University. Her work focuses on advancing reproductive genetics and improving maternal and childhood health outcomes through clinical research and thoughtful implementation of genomic technologies. Sophia’s interest in reproductive health began during her undergraduate studies at Wellesley College, a historically women’s college that shaped her strong commitment to maternal health and reproductive justice. This foundation continues to guide her work, which centers on advancing equitable, evidence-based care for pregnant individuals, newborns, and children.
At Stanford, Sophia works closely with Dr. Christina Tise on several research initiatives at the intersection of reproductive and pediatric genetics. She contributes to the BabySeq Project, a study using genome sequencing to identify actionable genetic risks in newborns, where she coordinates IRB submissions, pediatrician engagement, family recruitment and consent, and the return of results. Sophia also plays an active role in the TRIOS Study, which investigates the genetic causes of recurrent pregnancy loss. Her work explores participants’ experiences receiving genomic results and aims to improve counseling practices and outcomes for families navigating reproductive challenges. In addition, Sophia contributes to the GREGoR Consortium (Genomics Research to Elucidate the Genetics of Rare diseases), supporting efforts to identify novel disease genes and improve diagnostic yield for individuals with rare, undiagnosed conditions.
Sophia’s research and clinical interests include reproductive and prenatal genetics, rare disease genomics, bioethics, and equitable implementation of genomic medicine. She is passionate about proactive healthcare and advocating for effective health risk communication within families, with the goal of improving understanding, decision-making, and health outcomes across diverse populations.
Research interests: reproductive genetics, prenatal genetics, recurrent pregnancy loss, newborn genomic screening, rare disease genomics, bioethics, proactive healthcare, family health communication, equitable implementation of genomics -
Catherine Aftandilian
Clinical Associate Professor, Pediatrics - Hematology & Oncology
Current Research and Scholarly InterestsI conduct clinical research on the prevention, early diagnosis, and treatment of infectious complications in pediatric patients with leukemia.
-
Rajni Agarwal
Professor of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsHematopoietic Stem cell biology-created a SCID mouse model to study engraftment of cord blood derived hematopoietic cells and use of this model to develop gene transfer technology for Fanconi anemia.
Clinical research interests are to develop new protocols to reduce Toxicity from the conditioning regimens for stem cell transplants, reducing graft vs host disease, treatment of viral infections post transplant and use of manipulated HSC graft in patients who receive haplo donor transplants. -
Nima Aghaeepour
Anesthesiology, Perioperative and Pain Medicine Professor and Professor of Pediatrics (Neonatology) and of Biomedical Data Science
BioNima Aghaeepour is a machine learning and artificial intelligence scientist and the Anesthesiology, Perioperative and Pain Medicine II Endowed Professor, and Professor of Pediatrics, and of Biomedical Data Science at Stanford University. His laboratory develops computational methods to study clinical and biological modalities in translational settings.
Dr. Aghaeepour primarily focuses on leveraging multiomics studies, wearable devices, and electronic health records to address clinical challenges in perioperative care and maternal and child health, with a particular focus on interventional settings including operating rooms, ICUs, labor and delivery, and NICUs. Prior to his faculty role, Dr. Aghaeepour earned his B.Sc. in Computer Science from the University of Tehran, followed by a Ph.D. in Bioinformatics from the University of British Columbia and a postdoctoral fellowship at Stanford University.
Dr. Aghaeepour is an alumnus of Stanford's Graduate School of Business Ignite program, a Biodesign Faculty Fellow, and a SPARK fellow and his laboratory provides training on the interface of academia and entrepreneurship. He regularly co-founds or serves on scientific advisory boards of startup companies and is committed to fostering entrepreneurship among his trainees through Stanford's unique programs. Beyond his scientific pursuits, Dr. Aghaeepour is an experienced pilot, skydiver, and wingsuiter. -
Iram Ahmad, MD, MME
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioDr. Iram Ahmad received her MD from the University of Michigan Medical School. She then completed Otolaryngology residency program at the University of Iowa. At Iowa, she was an NIH- sponsored T32 research resident in the Department of Otolaryngology. During her residency training she also gained expertise in education and graduated with a Master in Medical Education from the University of Iowa Carver College of Medicine. After residency, Dr. Ahmad continued at Iowa for her fellowship in Pediatric Otolaryngology.
Dr. Ahmad is an Assistant Professor of Otolaryngology- Head and Neck Surgery in the Pediatric Division. Her clinical expertise is in Pediatric Otology and hearing loss. She is focused on children with hearing loss, cochlear implantation, cholesteatoma, and general pediatric Otolaryngology. Her research interests are in children with congenital hearing loss and microstructure changes of the brain. -
Meghali Aich
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioMy research interest lies in understanding how environmental factors contribute to neurodevelopmental disorders and translating those insights into therapies. Aligned with this, my current research in Dr. Anca Pasca’s lab at Stanford focuses on how reductive stress associated with maternal metabolic syndrome affects fetal brain development.
-
Chidi Akusobi
Fellow in Peds/Clinical Informatics
BioDr. Chidi Akusobi is a physician-scientist completing dual fellowship training in Infectious Diseases and Clinical Informatics at Stanford University School of Medicine. He holds an MD and a PhD in Microbiology from Harvard Medical School and completed internal medicine residency at Massachusetts General Hospital. His research sits at the intersection of AI and infectious diseases, with a focus on developing and evaluating AI-enabled tools that strengthen infectious disease practice. Current project interests include clinical decision support for infection prevention and control, AI-backed electronic consultation for infectious diseases, and the application of ChatEHR to ID-specific chart review.
-
Steven R. Alexander, MD
Professor of Pediatrics (Nephrology), Emeritus
Current Research and Scholarly InterestsDialysis, kidney transplantation, continuous renal replacement therapy in pediatric patients; chronic kidney disease in pediatric patients.
-
Jessica M. Allan
Adjunct Clinical Associate Professor, Pediatrics
BioDr. Jessie Allan, MD works as a Pediatric Hospitalist for Palo Alto Medical Foundation. She cares for patients in the Newborn Nursery, Intermediate Care Nursery, and on the inpatient wards at Stanford Children's Hospital. She serves as the chair-elect of the American Academy of Pediatrics, Section on Hospital Medicine.
-
Christopher Almond
Professor of Pediatrics (Cardiology)
BioChristopher Almond, MD, MPH is Professor of Pediatrics in the Division of Cardiology at the Stanford University School of Medicine where he is a board-certified pediatric cardiologist at Stanford's Lucile Packard Children's Hospital in Palo Alto, CA. His clinical and research interests are focused on pediatric heart failure, mechanical circulatory support, heart transplantation, and anticoagulation. He completed his training in pediatrics, cardiology, and a senior fellowship in heart failure/transplant at Boston Children's Hospital before before appointment as Assistant Professor of Pediatrics at Harvard Medical School/Boston Children’s Hospital. Dr. Almond completed his MPH at the Harvard School of Public Health with a focus on statistics and epidemiology (study design for rare diseases) followed by a Medical Device Fellowship at the FDA in the Division of Cardiovascular Devices at CDRH. Dr. Almond moved to Stanford in 2014 where he currently serves as professor of pediatrics and directs the clinical research program within Pediatric Advanced Cardiac Therapies (PACT) Program. He also serves as Medical Director of the Children’s Heart Center Anticoagulation Management Program at Stanford (CHAMPS). Dr. Almond has a passion for collaborative research serving as PI for federally-funded multi-center clinical trials including the Berlin Heart ventricular assist device (VAD) FDA Trial that led to its FDA approval in 2011, the TEAMMATE (everolimus for heart transplant) Trial, the TROLLEY (Cardiohelp ECMO/anticoagulation RCT in heart failure) Trial, the NHLBI PumpKIN (Jarvik 2015 LVAD) Trial, and the SPOT BIAS Trial, an FDA-funded trial to understand racial/pigment bias in commercial pulse oximeters.
-
Leina Alrabadi
Clinical Associate Professor, Pediatrics - Gastroenterology
BioI enjoy working with a multidisciplinary team to care for patients who have complex medical needs with the aim of giving children a better future. As a clinical researcher, my main focus is on finding improved therapies for autoimmune and cholestatic liver diseases, since an ideal therapy currently does not exist.
-
Dahham Alsoud, MD, MSc, PhD
Postdoctoral Scholar, Gastroenterology, Hepatology, and Nutrition
BioDr. Alsoud is a physician-scientist conducting postdoctoral research at the Rosen Lab, supported by fellowships from the Belgian American Educational Foundation and the Stanford Medicine Children’s Health Center for IBD and Celiac Disease. His research combines advanced statistical modeling and bioinformatics, leveraging multi-omics and longitudinal clinical data from the CAPTURE IBD cohort to uncover the molecular and clinical determinants of therapeutic outcomes. Through this work, he aims to reduce reliance on trial-and-error treatment strategies, strengthen evidence-based clinical decision-making, and ultimately improve outcomes and quality of life for individuals living with inflammatory bowel disease.
After earning his MD from Damascus University, Dr. Alsoud conducted his PhD research at KU Leuven, where he integrated clinical prediction, serum proteomics, and whole-blood transcriptomics to investigate treatment heterogeneity, therapeutic resistance, and response to advanced therapies in IBD. He also holds a Master of Science in Health Care Management and Policy from KU Leuven, reflecting his broader interest in designing efficient, patient- and provider-centered models of healthcare delivery. Dr. Alsoud serves as an Editorial Fellow for Basic and Translational Science at Inflammatory Bowel Diseases and has contributed to the peer review of more than 150 manuscripts in the field. -
Manuel R. Amieva
Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMy laboratory studies how bacteria colonize our bodies for long periods of time, and how interactions between bacteria and the epithelial surfaces of the gastrointestinal tract and skin may lead to disease. Epithelial surfaces are the first barrier against infection, but they also where our bodies meet and co-evolve with the microbial world.. Several of our studies have focused on the epithelial junctions as a target for bacterial pathogens. The host epithelium uses its epithelial junctions to form a tight but dynamic barrier with an external surface that is inhospitable to microbial attachment, secretes anti-microbial compounds, and has a rapid rate of self-renewal. The balance in the microbe-epithelial relationship results in silent commensalism or symbiosis; an imbalance results in diseases ranging from acute bacterial invasive disease to chronic ulcers or carcinoma.
Our laboratory has developed novel microscopy applications such as quantitative 3D confocal microscopy, electron microscopy, time-lapse imaging, microinjection and micromanipulation to visualize the interaction of pathogens with epithelial cells in culture and in animal and human tissues. Many of out studies focus on the gastric pathogen Helicobacter pylori, but we have also expanded our investigations to include the intestinal pathogens Listeria monocytogenes and Salmonella enterica, and the skin pathogen and colonizer Staphylococcus aureus. I believe that elucidating how microbes communicate with and alter our epithelial cells at a molecular level will be important for finding novel therapeutic targets to control mucosal colonization and prevent invasive disease.
Using this perspective, we have uncovered several novel concepts of how bacteria colonize and breach our epithelial surfaces. For example, we discovered that Helicobacter pylori target the intercellular junctions, and in particular that the virulence factor CagA affects junction assembly and cell polarity. This confers H. pylori the ability to extract nutrients and grow directly on the epithelial surface. We also found that these properties of CagA have consequences for cellular transformation of the epithelium. For instance, we showed that H. pylori affect the activity and state of epithelial stem cells in the stomach by colonizing the epithelial surface deep in the gastric glands. This gland-associated population is essential for pathological inflammation and hyperplasia in animal models, and confers significant colonization advantages to the bacteria. Our Listeria research uncovered a new mechanism and site where bacteria can breach the gastrointestinal epithelial barrier to invade. We found that Listeria find their receptor for invasion at sites of epithelial senescence, where the epithelial junctions undergo dynamic turnover. To study Salmonella and H. pylori we have developed a human organoid model to study their interactions with human gut epithelium in vitro. To study Staphylococcus aureus pathogenesis, we have developed methods to visualize infection at the scale of a single bacterial microcolony using an organoid culture system of human keratinocytes and fibroblasts that grow into a 3D skin-equivalent. We recently identified several proteins at the eptithelial junctions as host factors involved in the pathogenesis of one of Staphylococcus aureus major toxins. -
Michael Amylon
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsBone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.
-
Kanwaljeet S. Anand
Professor of Pediatrics (Pediatric Critical Care) and of Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsDr. Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children. His research focus over the past 30+ years has contributed fundamental knowledge about pediatric pain/stress, long-term effects of pain in early life, management of pain, mechanisms for opioid tolerance and withdrawal. Current projects in his laboratory are focused on developing biomarkers for repetitive pain/stress in critically ill children and the mechanisms underlying sedative/anesthetic neurotoxicity in the immature brain. He designed and directed many randomized clinical trials (RCT), including the largest-ever pediatric analgesia trial studying morphine therapy in ventilated preterm neonates. He has extensive experience in clinical and translational research from participating in collaborative networks funded by NIMH, NINDS, or NICHD, a track-record of excellent collaboration across multiple disciplines, while achieving success with large research teams like the Collaborative Pediatric Critical Care Research Network (CPCCRN). He played a leadership roles in CANDLE (Condition Affecting Neuro-Development & Learning in Early infancy) and other activities of the Urban Child Institute and UT Neuroscience Institute. More recently, he led the NeoOpioid Consortium funded by the European Commission, which collected data from 243 NICUs in 18 European countries.
-
Dev Andra
Affiliate, Pediatrics - Adolescent Medicine
BioI'm a rising sophomore at Monta Vista High School and a member of the Stanford REACH Lab Youth Action Board. As part of the Communications Subcommittee, I contribute to marketing and social media outreach for YAB initiatives and am currently co-leading the launch of Reaching Beyond, a new podcast by the REACH Lab YAB. In my free time, I enjoy coding, building and tinkering with AI projects, playing guitar, and competing in badminton.
-
Arash Anoshiravani
Clinical Professor, Pediatrics - Adolescent Medicine
Current Research and Scholarly InterestsResearch interests include high-risk youth, adolescent health services, and the juvenile justice system.
-
Eric Appel
Associate Professor of Materials Science and Engineering, Senior Fellow at the Woods Institute for the Environment and Associate Professor, by courtesy, of Pediatrics (Endocrinology) and of Bioengineering
Current Research and Scholarly InterestsThe underlying theme of the Appel Lab at Stanford University integrates concepts and approaches from supramolecular chemistry, natural/synthetic materials, and biology. We aim to develop supramolecular biomaterials that exploit a diverse design toolbox and take advantage of the beautiful synergism between physical properties, aesthetics, and low energy consumption typical of natural systems. Our vision is to use these materials to solve fundamental biological questions and to engineer advanced healthcare solutions.
-
Ronald L. Ariagno
Professor (Clinical) of Pediatrics, Emeritus
Current Research and Scholarly InterestsDevelopmental Physiology and Sudden Infant Death Syndrome Research Laboratory closed in 2008.
Current effort, as Chair of Task Force and neonatal consult at the FDA, is to establish through consensus a culture of investigation and collaboration for all clinical neonatology practices: academic, corporate and community based to maximize the opportunity to participate in research effort needed for the regulatory approval of neonatal therapeutics to improve the outcome of critically ill infants. -
Vincent Armenta
Administrative Operations Manager, Pediatrics - Cardiology
Current Role at StanfordAcademic Operations Manager
-
Julia Arndt
Medical Student Education Coordinator, Pediatrics
Current Role at StanfordMedical Student Education Coordinator - School of Medicine, Office of Pediatric Education
-
Parth Arora
Life Science Research Professional 1, Pediatrics - Pulmonary Medicine
BioParth is joining the School of Medicine as a Life Science Research Professional for the Department of Pediatrics. As a part of Dr. Christin Kuo’s Lab, Parth is driven to support the team’s mission and actively contribute to the intellectual environment of the lab. He recently graduated from the University of Illinois Chicago with a B.S. in Molecular and Cellular Biology. During his time at UIC, he has been a part of several research projects where he collaborated with Dr. Rhonda D. Kineman to design a research project to investigate variations in hepatic gene expression throughout the phases of the estrus cycle and study the impact of sexual dimorphism in the progression of the nonalcoholic fatty liver. He believes this position would be an excellent opportunity for him to apply his skills while engaging in multidisciplinary projects that would make a real-life impact. He is thrilled to receive this opportunity and looks forward to being a part of the Stanford Community.
-
Alisa Arunamata
Clinical Associate Professor, Pediatrics - Cardiology
BioDr. Alisa Arunamata is a pediatric cardiologist and Clinical Associate Professor in the Department of Pediatrics at Stanford University School of Medicine. She specializes in cardiac imaging of the fetus through adulthood and provides comprehensive care to families and patients from the time of fetal diagnosis to post-operative management after cardiac surgery. She has held a number of leadership positions in education and hospital administration. She led the Pediatric Cardiology Fellowship training program as the Program Director, was previously the Program Director of the Advanced Non-Invasive Imaging Fellowship as well as the Medical Director of Acute Cardiac Care at Lucile Packard Children's Hospital at Stanford. She is currently the Associate Medical Director of the Echocardiography Lab.
Dr. Arunamata has a deep interest in improving clinical outcomes for children with congenital and acquired heart disease, with a primary focus on refining the assessment and contribution of the right ventricle in disease and health.
She graduated early with a degree in Molecular and Cell Biology (Biochemistry) from the University of California, Berkeley, obtained her medical degree at New York University School of Medicine and completed pediatric residency and cardiology fellowship training at Stanford. She was elected to the Alpha Omega Alpha Medical Honor Society in 2019 and is a Fellow of the American College of Cardiology (FACC) and American Society of Echocardiography (FASE). -
Ann M. Arvin
Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology, Emerita
Current Research and Scholarly InterestsOur laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.
-
Ritu Asija
Clinical Professor, Pediatrics - Cardiology
BioI am a pediatric cardiac intensivist specializing in the care of infants, children, and adults with congenital heart disease and heart failure. As Associate Director of the Pulmonary Artery Reconstruction Program at Stanford, I coordinate multidisciplinary care for patients with complex pulmonary artery abnormalities and right ventricular dysfunction. My clinical and academic interests include innovation in pediatric cardiovascular care, physician well-being, and faculty development. Following my appointment as a Faculty Fellow at the Stanford Center for Biodesign (2019–2020), I have continued to develop novel technologies addressing unmet needs in pediatric medicine. I also serve as a Physician Resource Network supporter, providing peer support to the Stanford School of Medicine community, and have completed the Stanford WellMD Wellness Director course. In addition, I am pursuing coaching certification to further advance faculty development and mentorship. My institutional and national leadership roles include serving on the Stanford School of Medicine Appointments and Promotions Committee and as a member of the American Board of Pediatrics Cardiology Subboard.
-
David M. Axelrod, MD
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsVirtual Reality Congenital Heart Disease experience: The Stanford Virtual Heart. Currently engaged with 19 academic medical centers across the globe using our Stanford Virtual Heart to educate students and trainees, and research our VR experience as a means for training and education. Also developing next generation modeling and image interaction with Stanford engineers and educators, to promote personalized surgical training in VR and advanced educational programs in congenital heart disease.
-
Rosa Bacchetta
Professor (Research) of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsIn the coming years, I plan to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. I believe that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. I plan to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.
Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.
For further information please visit the Bacchetta Lab website:
http://med.stanford.edu/bacchettalab.html -
Laura K. Bachrach
Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emerita
Current Research and Scholarly InterestsPrevention of osteoporosis begins in childhood and adolescence by measures that maximize acquistion of bone mineral during the critical adolescent years. Body mass, calcium nutriture, physical activity, growth and sex steroid hormones, and genetic factors are all thought to be important determinants of bone mass although the relative contribution of each remains controversial.
-
Justin Nathaniel Baker
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics
BioAs a Pediatric Oncologist, Palliative Care Physician, and Phase I and End– of– Life Care Clinical Investigator, I am intimately aware of the distress experienced by children with advanced cancer and the ethical and end– of– life/bereavement issues surrounding their disease progression. I currently serve as the Chief of the Division of Quality of Life and Pediatric Palliative Care here at Stanford, as well as the Director of the Quality of Life for All (QoLA) Program. Additionally, I serve as the Associate Chief Quality Officer for Patient Experience and Holistic Care. In my past career at St Jude, I served as the Director of our large Pediatric Hematology/Oncology Fellowship Program for more than a decade. My research interests include ethical considerations surrounding enrollment in Phase I clinical trials, AYA palliative oncology care, end– of– life decision making, grief and bereavement, integrating palliative care into the ongoing care of children with cancer as well as patient– reported outcomes and pain and symptom control in the context of pediatric oncology care. I have received significant extramural funding for my research, and I have participated in dozens of studies related to pediatric palliative care. I have authored ~300 academic works on a broad array of palliative care subjects. In sum, I am a recognized global expert and leader in the field of Pediatric Palliative Care.
-
Karthik Balakrishnan, MD, MPH, FAAP, FACS
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsDr. Balakrishnan's research focuses on innovative ways to improve and standardize treatments and measure outcomes in complex pediatric airway and aerodigestive conditions , as well as ways to reduce treatment costs and medical errors. By improving outcomes and reducing costs, he aims to improve the value of care, while also optimizing patient and caregiver experience during the care process.
-
Malathi Balasundaram
Clinical Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsFamily-centered Care in the NICU
-
Imelda Balboni
Clinical Associate Professor, Pediatrics - Rheumatology
Current Research and Scholarly InterestsPediatric systemic lupus erythematosus;
Autoimmune disease;
Proteomics and autoantigen microarray technology
